Here, we isolated cisplatin-resistant HNCSCs from a HNSCC cell line, identified pathways active in cisplatin-resistant HNCSCs by using microarray analysis, and then investigated the role of a candidate gene, FGF2, in resistance of HNCSCs to chemotherapy. This evidence concerns the gene FGF2 and head and neck squamous cell carcinoma.